Forgot Password

  • Occams Business Research & Consulting Pvt. Ltd

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Pharmaceuticals » HPH-4251116
  • Global Glucosamine Market- Technologies, Market share and Industry Forecast to 2024

  • Publish: November 2016 | Report Code: HPH-4251116

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Glucosamine is an amino derivative of glucose. It is the part of polysaccharides and a basic structure unit of chitin. It is highly used in dietary supplements and pharmaceuticals. The global glucosamine market is expected to have the CAGR of 10.9% during period 2016-2023. There is high prevalence of arthritis and joint pain diseases globally which is highly impacting the glucosamine market as glucosamine is an important ingredient of the medicine used for treating joint pain and arthritis diseases. So the rising cases of arthritis diseases will increase the demand for medicines which positively impact the glucosamine market. According to the World Health Organization there are 9.6% of men and 18.0% of women who are aged above 60 years are suffering from symptomatic arthritis. Rising geriatric population is the prime factor driving global glucosamine market for the forecast period. National Institute of Health’s report, An Aging World 2015, estimated the world’s geriatric population (aged 65 and over) to be 8.5% in 2015. The report predicts geriatric population to reach around 17% by 2050.  Men and women above 65 years tend to suffer from arthritis and other joint pain diseases. By the year 2040, more than 78 million people aged 18 years and above will suffer from one or other form of Osteoarthritis (OA). Expenditures towards OA treatment for US government alone costs approx. $62.1billion every year.

Proper disposal and recycling technique, low awareness of glucosamine material in emerging economies, and traceability & control of supply chain are the challenges faced by the key market players in the glucosamine market. Majority doctors prescribe glucosamine to regulate OA disease. Emerging economies like India and China are increasing investments for preventive healthcare for the forecasted period. The glucosamine market is segmented in terms of applications. Dairy product is among the known common application of glucosamine. Glucosamine in dairy products market are estimated to reach $57million by 2020, at CAGR 15%. By 2025, countries like India, Pakistan, US, and China will be leading producers of milk and dairy products growing at 3 % annually.

 

Source: OBRC Analysis

The research report is segmented on the basis of type and applications. On the basis of type, the market segmented into:

  • N- acetyl glucosamine,
  • Glucosamine HCL ,
  • Glucosamine Sulphate ,
  • Glucosamine Acetyl
  • Poly-N-Acetyl-Glucosamine (Poly NAG)  







Under application, the research report is segmented into:

  • Nutritional Supplements
  • Food & Beverage
  • Dairy Products
  • Feed Additives
  • Pharmaceuticals






Food & beverage is one of the fastest rising application segments. Europe and Asia Pacific are the leading regions in food & beverage market. The global demand in food & beverage is expected to have the CAGR of 15% (11,700tons) by 2020. Japan is the fastest rising consumer market for glucosamine in food and beverage. Japan has over 26% of its total population aged 65 years and above. Geriatric population in Japan is estimated to increase at 4% per annum. Glucosamine market in Japan is growing at CAGR 17% till 2020. Nutritional supplement was leading application segment of glucosamine in the world with market share of 35% in 2015. The nutritional supplement market is growing fastest in US. US accounted for the largest market share (of 71%) in North America for glucosamine. Growing geriatric population and health conscious working people are the contributing factors towards nutritional supplement market growth. Nutritional supplement market share of North America was 27% in 2015. Asia Pacific is expected to have the fastest growth rate  for nutritional supplement with CAGR of 12.5% by 2022. Increasing geriatric population in China, Japan, and Australia are the main drivers of nutritional supplement market in Asia Pacific.

The revenue for the above application  segments are specific to the global glucosamine market. however, the total revenue of these application in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up type segment. Region wise the glucosamine market is segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World.





North America dominated the glucosamine market with market share of 32% in 2015. North America is followed closely by Europe with market share of 29% in 2015. Awareness regarding glucosamine and nutritional supplements, increasing geriatric population and growing food & beverage industry adopting glucosamine in their products are the factors driving the market in North America and Europe for the forecast period. Asia Pacific is the fastest growing glucosamine market for the forecast period and is expected to have market share of 34% by 2022. In 2015, Asia Pacific had over 38% of the world’s total geriatric population. Every five years geriatric population in Asia Pacific grows at 22%. Increasing geriatric population, increasing health conscious working people, rising adoption of food & beverage, and growing vegan population are the factors driving glucosamine market in Asia Pacific for the forecasted period. Geriatric population in India is estimated to increase up to 3.75% by 2021. Countries like Japan, India, China, Indonesia and Vietnam are among the growing markets for glucosamine in Asia Pacific. Nutritional supplements demand is growing in India, with growing awareness among working youth population. Food Safety and Standards Act 2006 and Food & Drug Administration’s Orphan Drug Act Amendments 1988 are the reference points for regulations for food products including nutritional supplements to be sold in the country.

The major market players of the global glucosamine market are:

  • ALFA CHEM,
  • CARGILL INC.
  • FABRICHEM INC.
  • GOLDEN SHELL BIOCHEMICAL CO LTD.
  • KOYO CHEMICAL COMPANY LTD.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.







Detailed analysis of these companies provided in this report comprises of overview, SCOT analysis, product portfolio, strategic initiative and strategic analysis.

Joint ventures, agreements, partnerships, collaborations, expansion in different countries, and strengthening supply chain network with distributors are some of the strategies taken by pioneers in glucosamine market, to increase their global presence. Example: Frutarom Inc., bought 100% shares of nutritional supplement manufacturer, Grow Company Inc., US, for $20million on 18th January 2016.

On 29th September 2016, TSI Group Co Ltd., launched GlucosaGreenDF world’s first non-shellfish glucosamine product. TSI Group Co Ltd has their presence in Europe and North America.

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such as product launch that is on29th September 2016, TSI Group Co Ltd., launched GlucosaGreenDF worlds first non-shellfish glucosamine product
  • Provide in detail description about segments which affect the global glucosamine market.
  • Provide you the patent analysis of the global glucosamine market.
  • Identify and understand the strengths, opportunities, challenges and threats of the glucosamine market.
  • Provide revenues of major players of the market such as Alfa Chem, Cargill Inc, Teva Pharmaceutical Industries Ltd.
  • Provide you various regulatory policies which affect the global glucosamine market.







How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global glucosamin market offers the longest chain of market segmentation covering major market segmentation based on application and type. The report tracks the major market trends in the global glucosamine market such as increasing prevalence of arthritis and other joint pain diseases. For each market segments covered in global glucosamine market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the glucosamine industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360-degree analysis, See Saw analysis, and Porter five force model and so on. For the high-level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings of the global glucosamine market:

  • Growing awareness about glucosamine and nutritional supplements, increasing geriatric population and growing food & beverage industry adopting glucosamine in their products are the factors driving the global glucosamine market.
  • North America had the largest revenue share in 2016.
  • Food & beverage is one of the fastest growing application segment.
  • Product launch is the key strategy adopted by the various market players of global glucosamine market.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL GLUCOSAMINE MARKET : EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE 
2.3. INDUSTRY STRUCTURE
2.4. TOTAL MARKET ANALYSIS
2.4.1. TOP 5 FINDINGS
2.4.2. TOP 5 OPPORTUNITY MARKETS
2.4.3. TOP 5 COMPANIES     
2.4.4. TOP 3 COMPETITIVE STRATEGIES
2.5. ESTIMATION ANALYSIS     
2.6. STRATEGIC ANALYSIS
2.6.1. INVESTMENT VS. ADOPTION MODEL
2.6.2. 360-DEGREE INDUSTRY ANALYSIS
2.6.3. PORTERS 5 FORCE MODEL
2.6.4. SEE-SAW ANALYSIS
2.6.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7. COMPETITIVE ANALYSIS
2.7.1. KEY STRATEGIES & ANALYSIS
2.7.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. GROWING GERIATRIC POPULATION
3.1.2. ADOPTION OF GLUCOSAMINE IN EMERGING ECONOMIES
3.1.3. INCREASING ADOPTION OF FOOD & BEVERAGES
3.1.4. INCREASING PREVALENCE OF ARTHRITIS AND OTHER JOINT PAIN DISEASES
3.1.5. RISING VEGAN DIET POPULATION 
3.2. MARKET RESTRAINTS
3.2.1. HIGH COST OF GLUCOSAMINE PRODUCTS
3.2.2. LESS CONSUMPTION IN EMERGING ECONOMIES
3.2.3. STRINGENT REGULATORY RULES TOWARDS FMCG’S 
3.3. MARKET OPPORTUNITIES
3.3.1. INCREASING DEMAND IN EMERGING ECONOMIES
3.3.2. AGING POPULATION
3.4.   MARKET CHALLENGES 
3.4.1. PROPER DISPOSAL AND RECYCLING TECHNIQUE
3.4.2. LOW AWARENESS OF GLUCOSAMINE MATERIAL IN EMERGING ECONOMIES
3.4.3. TRACEABILITY & CONTROL OF SUPPLY CHAIN 
 
4. GLOBAL GLUCOSAMINEMARKET BY TYPE
4.1. MARKET DEFINITION AND SCOPE
4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4. OPPORTUNITY MATRIX
4.5. MARKET SEGMENTATION 
4.5.1. GLOBAL GLUCOSAMINE MARKETN-ACETYL-GLUCOSAMINE MARKET 
4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.1.3. KEY CONCLUSIONS
4.5.2. GLOBAL GLUCOSAMINE MARKETGLUCOSAMINE HCL MARKET 
4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.2.3. KEY CONCLUSIONS
4.5.3. GLOBAL GLUCOSAMINE MARKETGLUCOSAMINE SULPHATE MARKET 
4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.3.3. KEY CONCLUSIONS
4.5.4. GLOBAL GLUCOSAMINE MARKETPOLY-N-ACETYL-GLUCOSAMINE (POLY NAG) MARKET
4.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.4.3. KEY CONCLUSIONS
 
5. GLOBAL GLUCOSAMINEMARKET BY APPLICATION
5.1. MARKET DEFINITION AND SCOPE
5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
5.4. OPPORTUNITY MATRIX
5.5. MARKET SEGMENTATION 
5.5.1. GLOBAL NUTRITIONAL SUPPLEMENTS APPLICATION MARKET 
5.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
5.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
5.5.1.3. KEY CONCLUSIONS
5.5.2. GLOBAL FOOD AND BEVERAGES APPLICATION MARKET 
5.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
5.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
5.5.2.3. KEY CONCLUSIONS
5.5.3. GLOBAL DAIRY PRODUCTS APPLICATION MARKET 
5.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
5.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
5.5.3.3. KEY CONCLUSIONS
5.5.4. GLOBAL  PHARMACEUTICALS APPLICATION MARKET 
5.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
5.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
5.5.4.3. KEY CONCLUSIONS
5.5.5. GLOBAL FEED ADDITIVES APPLICATION MARKET 
5.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
5.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
5.5.5.3. KEY CONCLUSIONS
 
6. COMPETITIVE LANDSCAPE
6.1. KEY STRATEGIES
6.1.1. LIST OF MERGERS AND ACQUISITION
6.1.2. LIST OF JOINT VENTURES
6.1.3. LIST OF PRODUCT LAUNCHES
6.1.4. LIST OF PARTNERSHIPS
 
7. GEOGRAPHIC ANALYSIS
7.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
7.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
7.3. OPPORTUNITY MATRIX
7.4. GLOBAL GLUCOSAMINEMARKET BY REGION 2015-2024  
7.4.1. NORTH AMERICA
7.4.1.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
7.4.1.2. TOP COUNTRY ANALYSIS
7.4.1.2.1. U.S. 
7.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.1.2.1.2. KEY CONCLUSIONS
7.4.1.2.2. CANADA
7.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.1.2.2.2. KEY CONCLUSIONS
7.4.2. EUROPE
7.4.2.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
7.4.2.2. TOP COUNTRY ANALYSIS
7.4.2.2.1. UK
7.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.2.2.1.2. KEY CONCLUSIONS
7.4.2.2.2. FRANCE
7.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.2.2.2.2. KEY CONCLUSIONS
7.4.2.2.3. GERMANY
7.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.2.2.3.2. KEY CONCLUSIONS
7.4.2.2.4. SPAIN
7.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.2.2.4.2. KEY CONCLUSIONS
7.4.2.2.5. REST OF EUROPE
7.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.2.2.5.2. KEY CONCLUSIONS
7.4.3. ASIA PACIFIC
7.4.3.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
7.4.3.2. TOP COUNTRY ANALYSIS
7.4.3.2.1. CHINA
7.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.3.2.1.2. KEY CONCLUSIONS
7.4.3.2.2. INDIA
7.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.3.2.2.2. KEY CONCLUSIONS
7.4.3.2.3. JAPAN
7.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.3.2.3.2. KEY CONCLUSIONS
7.4.3.2.4. AUSTRALIA
7.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.3.2.4.2. KEY CONCLUSIONS
7.4.3.2.5. REST OF ASIA PACIFIC
7.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.3.2.5.2. KEY CONCLUSIONS
7.4.4. ROW
7.4.4.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
7.4.4.2. TOP COUNTRY ANALYSIS
7.4.4.2.1. LATIN AMERICA
7.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.4.2.1.2. KEY CONCLUSIONS
7.4.4.2.2. MIDDLE EAST & AFRICA 
7.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
7.4.4.2.2.2. KEY CONCLUSIONS
 
8. COMPANY PROFILES
8.1. ALFA CHEM (U.S)
8.1.1. OVERVIEW
8.1.2. PRODUCT PORTFOLIO
8.1.3. STRATEGIC INITIATIVES 
8.1.4. SCOT ANALYSIS
8.1.5. STRATEGIC ANALYSIS
 
8.2. ALCAN CHEMICAL DIVISION(US) 
8.2.1. OVERVIEW 
8.2.2. PRODUCT PORTFOLIO
8.2.3. STRATEGIC INITIATIVES 
8.2.4. SCOT ANALYSIS
8.2.5. STRATEGIC ANALYSIS
 
8.3. CARGILL INC(US) 
8.3.1. OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. STRATEGIC INITIATIVES 
8.3.4. SCOT ANALYSIS
8.3.5. STRATEGIC ANALYSIS
 
8.4. FABRICHEM INC(US) 
8.4.1. OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVES 
8.4.4. SCOT ANALYSIS
8.4.5. STRATEGIC ANALYSIS
 
8.5. GOLDEN SHELL BIOCHEMICAL CO LTD(CHINA) 
8.5.1. OVERVIEW 
8.5.2. PRODUCT PORTFOLIO
8.5.3. STRATEGIC INITIATIVES 
8.5.4. SCOT ANALYSIS
8.5.5. STRATEGIC ANALYSIS
 
8.6. MARINE BIOCHEMICAL CO LTD(CHINA) 
8.6.1. OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. STRATEGIC INITIATIVES 
8.6.4. SCOT ANALYSIS
8.6.5. STRATEGIC ANALYSIS
 
8.7. NAVAMEDIC ASA(SWEDEN) 
8.7.1. OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. STRATEGIC INITIATIVES 
8.7.4. SCOT ANALYSIS
8.7.5. STRATEGIC ANALYSIS
 
8.8. NUTRACEUTIX INC(US) 
8.8.1. OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. STRATEGIC INITIATIVES 
8.8.4. SCOT ANALYSIS
8.8.5. STRATEGIC ANALYSIS
 
8.9. KOYO CHEMICAL COMPANY LTD
8.9.1. OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. STRATEGIC INITIATIVES 
8.9.4. SCOT ANALYSIS
8.9.5. STRATEGIC ANALYSIS
 
8.10. NUTRILITE
8.10.1. OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. STRATEGIC INITIATIVES 
8.10.4. SCOT ANALYSIS
8.10.5. STRATEGIC ANALYSIS
 
8.11. SCHIFF NUTRITION INTERNATIONAL INC(US) 
8.11.1. OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. STRATEGIC INITIATIVES 
8.11.4. SCOT ANALYSIS
8.11.5. STRATEGIC ANALYSIS
 
8.12. SIMPY SUPPLEMENTS(UK) 
8.12.1. OVERVIEW
8.12.2. PRODUCT PORTFOLIO
8.12.3. STRATEGIC INITIATIVES 
8.12.4. SCOT ANALYSIS
8.12.5. STRATEGIC ANALYSIS
 
8.13. TRIARCO INDUSTRIES INC(US)
8.13.1. OVERVIEW  
8.13.2. PRODUCT PORTFOLIO
8.13.3. STRATEGIC INITIATIVES 
8.13.4. SCOT ANALYSIS
8.13.5. STRATEGIC ANALYSIS
 
8.14. SYNASIA INC(US) 
8.14.1. OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. STRATEGIC INITIATIVES 
8.14.4. SCOT ANALYSIS 
8.14.5. STRATEGIC ANALYSIS
 
8.15. TEVA PHARMACEUTICAL INDUSTRIES LTD.(ISRAEL)
8.15.1. OVERVIEW
8.15.2. PRODUCT PORTFOLIO
8.15.3. STRATEGIC INITIATIVES 
8.15.4. SCOT ANALYSIS 
8.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
1. GLOBAL GLUCOSAMINEMARKET BY TYPE 2015-2024 ($ MILLION)
2. GLOBAL GLUCOSAMINE MARKETN-ACETYL-GLUCOSAMINE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
3. GLOBAL GLUCOSAMINE MARKETGLUCOSAMINE HCL MARKET BY GEOGRAPHY 2015-2024 ($ MILLION) 
4. GLOBAL GLUCOSAMINE MARKETGLUCOSAMINE SULPHATE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
5. GLOBAL GLUCOSAMINE MARKETGLUCOSAMINE ACETYL MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
6. GLOBAL GLUCOSAMINE MARKETPOLY-N-ACETYL-GLUCOSAMINE (POLY NAG) MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
7. GLOBAL GLUCOSAMINEMARKET BY APPLICATIONS 2015-2024 ($ MILLION)
8. GLOBAL NUTRITIONAL SUPPLEMENTS APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
9. GLOBAL FOOD AND BEVERAGES APPLICATION  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
10. GLOBAL DAIRY PRODUCTS APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
11. GLOBAL PHARMACEUTICALS APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
12. GLOBAL FEED ADDITIVES APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
13. NORTH AMERICA GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
14. EUROPE GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
15. ASIA PACIFIC GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
16. REST OF THE WORLD GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
17. NORTH AMERICA GLUCOSAMINEMARKET BY TYPE 2015-2024 ($ MILLION)
18. EUROPE GLUCOSAMINEMARKET BY TYPE 2015-2024 ($ MILLION)
19. ASIA PACIFIC GLUCOSAMINEMARKET BY TYPE 2015-2024 ($ MILLION)
20. REST OF THE WORLD GLUCOSAMINEMARKET BY TYPE 2015-2024 ($ MILLION)
21. NORTH AMERICA GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)
22. EUROPE GLUCOSAMINEMARKET BY APPLICATION 2015-2024 ($ MILLION)
23. ASIA PACIFIC GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)
24. REST OF THE WORLD GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)
25. UNITED STATES GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)
26. UNITED STATES GLUCOSAMINE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
27. CANADA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)
28. CANADA GLUCOSAMINE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
29. UK GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)
30. UK GLUCOSAMINE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
31. FRANCE GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)
32. FRANCE GLUCOSAMINE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
33. GERMANY GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)
34. GERMANY GLUCOSAMINE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
35. SPAIN GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)
36. SPAIN GLUCOSAMINE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
37. ROE GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)
38. ROE GLUCOSAMINE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
39. CHINA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)
40. CHINA GLUCOSAMINE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
41. INDIA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)
42. INDIA GLUCOSAMINE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
43. JAPAN GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)
44. JAPAN GLUCOSAMINE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
45. AUSTRALIA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)
46. AUSTRALIA GLUCOSAMINE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
47. ROAPAC GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)
48. ROAPAC GLUCOSAMINE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
49. LATIN AMERICA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)
50. LATIN AMERICA GLUCOSAMINE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
 
LIST OF FIGURES
1. GLOBAL GLUCOSAMINE MARKETN-ACETYL-GLUCOSAMINE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
2. GLOBAL GLUCOSAMINE MARKETGLUCOSAMINE HCL MARKET BY GEOGRAPHY 2015-2024 ($ MILLION) 
3. GLOBAL GLUCOSAMINE MARKETGLUCOSAMINE SULPHATE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
4. GLOBAL GLUCOSAMINE MARKETGLUCOSAMINE ACETYL MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
5. GLOBAL GLUCOSAMINE MARKETPOLY-N-ACETYL-GLUCOSAMINE (POLY NAG) MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
6. GLOBAL NUTRITIONAL SUPPLEMENTS APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
7. GLOBAL FOOD AND BEVERAGES APPLICATION  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
8. GLOBAL DAIRY PRODUCTS APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
9. GLOBAL PHARMACEUTICALS APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
10. GLOBAL FEED ADDITIVES APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
11. UNITED STATES (U.S.) GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
12. CANADA GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
13. UNITED KINGDOM (UK) GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
14. FRANCE GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
15. GERMANY GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
16. SPAIN GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
17. ROE GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
18. CHINA GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
19. INDIA GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
20. JAPAN GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
21. AUSTRALIA GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
22. ROAPAC GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
23. LATIN AMERICA GLUCOSAMINEMARKET 2015-2024 ($ MILLION)
24. MENA GLUCOSAMINEMARKET 2015-2024 ($ MILLION)  
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: info@occamsresearch.com

 

 

Go To Top
viewthroughconversion